Controlled protein delivery from electrospun non-wovens: Novel combination of protein crystals and a biodegradable release matrix

Molecular Pharmaceutics

Volumn 11, Issue 7, 2014, Pages 2372-2380

  Puhl, Sebastian ^a   Li, Linhao ^a,b   Meinel, Lorenz ^a   Germershaus, Oliver ^a,c  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b CHONGQING UNIVERSITY   (China)

^c UNIVERSITY OF APPLIED SCIENCES AND ARTS NORTHWESTERN SWITZERLAND   (Switzerland)

Author keywords

electrospinning; poly(caprolactone); poly(lactic glycolic acid); protein crystal; protein delivery

Indexed keywords

LYSOZYME; MACROGOL; POLYCAPROLACTONE; POLYGLACTIN; POLYSORBATE 80; SOLVENT; CAPROLACTONE; HEXANOIC ACID DERIVATIVE; LACTIC ACID; LACTONE; MACROGOL DERIVATIVE; POLYGLYCOLIC ACID; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER; POLYMER; PROTEIN; SUSPENSION;

ARTICLE; BACTERIAL CELL WALL; BIODEGRADABILITY; BIOLOGICAL ACTIVITY; CRYSTALLIZATION; DRUG DELIVERY SYSTEM; DRUG RELEASE; ELECTROSPINNING; ENCAPSULATION; GONIOMETRY; MATRIX CONTROLLED DRUG DELIVERY; MICROCOCCUS LUTEUS; MORPHOLOGY; PARTICLE SIZE; PHASE SEPARATION; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN UNFOLDING; SURFACE TENSION; SUSPENSION; THERMODYNAMICS; VISCOSITY; WETTABILITY; CHEMISTRY; PROCEDURES;

CAPROATES; CRYSTALLIZATION; DRUG DELIVERY SYSTEMS; LACTIC ACID; LACTONES; MURAMIDASE; PARTICLE SIZE; POLYETHYLENE GLYCOLS; POLYGLYCOLIC ACID; POLYMERS; PROTEINS; SOLVENTS; SUSPENSIONS;

EID: 84903955068     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp5001026     Document Type: Article

References (38)

1. Formhals, A. Apparatus for Producing Artificial Filaments from Material such as Cellulose Acetate. 1934. U.S. patent 1,975,504.
2. Formhals, A. Method and apparaturs for spinning. 1937. U.S. patent 2,349,950.
3. Meinel, A. J.; Germershaus, O.; Luhmann, T.; Merkle, H. P.; Meinel, L. Electrospun matrices for localized drug delivery: Current technologies and selected biomedical applications Eur. J. Pharm. Biopharm. 2012, 81 (1) 1-13
4. Dash, T. K.; Konkimalla, V. B. Poly-μ-caprolactone based formulations for drug delivery and tissue engineering: A review J. Controlled Release 2012, 158 (1) 15-33
5. Cipitria, A.; Skelton, A.; Dargaville, T. R.; Dalton, P. D.; Hutmacher, D. W. Design, fabrication and characterization of PCL electrospun scaffolds: A review J. Mater. Chem. 2011, 21 (26) 9419-9453
6. Chen, D. R.; Bei, J. Z.; Wang, S. G. Polycaprolactone microparticles and their biodegradation Polym. Degrad. Stab. 2000, 67 (3) 455-459
7. Zong, X. H.; Li, S.; Chen, E.; Garlick, B.; Kim, K. S.; Fang, D. F.; Chiu, J.; Zimmerman, T.; Brathwaite, C.; Hsiao, B. S.; Chu, B. Prevention of postsurgery-induced abdominal adhesions by electrospun bioabsorbable nanofibrous poly(lactide-co-glycolide)-based membranes Ann. Surg. 2004, 240 (5) 910-915
8. Cao, X. D.; Shoichet, M. S. Delivering neuroactive molecules from biodegradable microspheres for application in central nervous system disorders Biomaterials 1999, 20 (4) 329-339
9. Maretschek, S.; Greiner, A.; Kissel, T. Electrospun biodegradable nanofiber nonwovens for controlled release of proteins J. Controlled Release 2008, 127 (2) 180-187
10. Li, Y.; Jiang, H. L.; Zhu, K. J. Encapsulation and controlled release of lysozyme from electrospun poly(μ-caprolactone)/poly(ethylene glycol) non-woven membranes by formation of lysozyme-oleate complexes J. Mater. Sci.: Mater. Med. 2008, 19 (2) 827-832
11. Lu, C. H.; Lin, W. J. Permeation of protein from porous poly(μ-caprolactone) films J. Biomed. Mater. Res. 2002, 63 (2) 220-225
12. Shenoy, B.; Wang, Y.; Shan, W. Z.; Margolin, A. L. Stability of crystalline proteins Biotechnol. Bioeng. 2001, 73 (5) 358-369
13. Yang, M. X.; Shenoy, B.; Disttler, M.; Patel, R.; McGrath, M.; Pechenov, S.; Margolin, A. L. Crystalline monoclonal antibodies for subcutaneous delivery Proc. Natl. Acad. Sci. U.S.A. 2003, 100 (12) 6934-6939
14. Elkordy, A. A.; Forbes, R. T.; Barry, B. W. Integrity of crystalline lysozyme exceeds that of a spray-dried form Int. J. Pharm. 2002, 247 (1-2) 79-90
15. Pechenov, S.; Shenoy, B.; Yang, M. X.; Basu, S. K.; Margolin, A. L. Injectable controlled release formulations incorporating protein crystals J. Controlled Release 2004, 96 (1) 149-158
16. Muller, C.; Ulrich, J. The dissolution phenomenon of lysozyme crystals Cryst. Res. Technol. 2012, 47 (2) 169-174
17. Falkner, J. C.; Al-Somali, A. M.; Jamison, J. A.; Zhang, J. Y.; Adrianse, S. L.; Simpson, R. L.; Calabretta, M. K.; Radding, W.; Phillips, G. N.; Colvin, V. L. Generation of size-controlled, submicrometer protein crystals Chem. Mater. 2005, 17 (10) 2679-2686
18. Bueno, V. B.; Petri, D. F. Xanthan hydrogel films: Molecular conformation, charge density and protein carriers Carbohydr. Polym. 2014, 101, 897-904
19. Charernsriwilaiwat, N.; Opanasopit, P.; Rojanarata, T.; Ngawhirunpat, T. Lysozyme-loaded, electrospun chitosan-based nanofiber mats for wound healing Int. J. Pharm. 2012, 427 (2) 379-384
20. Nakatsuji, T.; Gallo, R. L. Antimicrobial peptides: Old molecules with new ideas J. Invest. Dermatol. 2012, 132 (3, Part 2) 887-895
21. Pham, Q. P.; Sharma, U.; Mikos, A. G. Electrospun poly(μ-caprolactone) microfiber and multilayer nanofiber/microfiber scaffolds: Characterization of scaffolds and measurement of cellular infiltration Biomacromolecules 2006, 7 (10) 2796-2805
22. Liao, Y. H.; Brown, M. B.; Martin, G. P. Turbidimetric and HPLC assays for the determination of formulated lysozyme activity J. Pharm. Pharmacol. 2001, 53 (4) 549-554
23. Washburn, E. W. Note on a Method of Determining the Distribution of Pore Sizes in a Porous Material Proc. Natl. Acad. Sci. U.S.A. 1921, 7 (4) 115-116
24. Washburn, E. W. The dynamics of capillary flow Phys. Rev. 1921, 17, 273-283
25. Zang, Y. G.; Kammerer, B.; Eisenkolb, M.; Lohr, K.; Kiefer, H. Towards Protein Crystallization as a Process Step in Downstream Processing of Therapeutic Antibodies: Screening and Optimization at Microbatch Scale PLoS One 2011, 6 (9) e25282
26. Hebel, D.; Huber, S.; Stanislawski, B.; Hekmat, D. Stirred batch crystallization of a therapeutic antibody fragment J. Biotechnol. 2013, 166 (4) 206-211
27. Miller, M. A.; Engstrom, J. D.; Ludher, B. S.; Johnston, K. P. Low Viscosity Highly Concentrated Injectable Nonaqueous Suspensions of Lysozyme Microparticles Langmuir 2010, 26 (2) 1067-1074
28. Govardhan, C.; Khalaf, N.; Jung, C. W.; Simeone, B.; Higbie, A.; Qu, S.; Chemmalil, L.; Pechenov, S.; Basu, S. K.; Margolin, A. L. Novel long-acting crystal formulation of human growth hormone Pharm. Res. 2005, 22 (9) 1461-1470
29. Elkordy, A. A.; Forbes, R. T.; Barry, B. W. Stability of crystallised and spray-dried lysozyme Int. J. Pharm. 2004, 278 (2) 209-219
30. Gandhi, M.; Srikar, R.; Yarin, A. L.; Megaridis, C. M.; Gemeinhart, R. A. Mechanistic Examination of Protein Release from Polymer Nanofibers Mol. Pharmaceutics 2009, 6 (2) 641-647
31. Williamson, M. R.; Chang, H. I.; Coombes, A. G. A. Gravity spun polycaprolactone fibres: Controlling release of a hydrophilic macromolecule (ovalbumin) and a lipophilic drug (progesterone) Biomaterials 2004, 25 (20) 5053-5060
32. Finkelstein, A.; McClean, D.; Kar, S.; Takizawa, K.; Varghese, K.; Baek, N.; Park, K.; Fishbein, M. C.; Makkar, R.; Litvack, F.; Eigler, N. L. Local drug delivery via a coronary stent with programmable release pharmacokinetics Circulation 2003, 107 (5) 777-784
33. Zeng, J.; Aigner, A.; Czubayko, F.; Kissel, T.; Wendorff, J. H.; Greiner, A. Poly(vinyl alcohol) nanofibers by electrospinning as a protein delivery system and the retardation of enzyme release by additional polymer coatings Biomacromolecules 2005, 6 (3) 1484-1488
34. Bolgen, N.; Menceloglu, Y. Z.; Acatay, K.; Vargel, I.; Piskin, E. In vitro and in vivo degradation of non-woven materials made of poly(μ-caprolactone) nanofibers prepared by electrospinning under different conditions J. Biomater. Sci., Polym. Ed. 2005, 16 (12) 1537-1555
35. Srikar, R.; Yarin, A. L.; Megaridis, C. M.; Bazilevsky, A. V.; Kelley, E. Desorption-limited mechanism of release from polymer nanofibers Langmuir 2008, 24 (3) 965-974
36. Siparsky, G. L.; Voorhees, K. J.; Miao, F. D. Hydrolysis of polylactic acid (PLA) and polycaprolactone (PCL) in aqueous acetonitrile solutions: Autocatalysis J. Environ. Polym. Degrad. 1998, 6 (1) 31-41
37. Anderson, J. M.; Shive, M. S. Biodegradation and biocompatibility of PLA and PLGA microspheres Adv. Drug Delivery Rev. 1997, 28 (1) 5-24
38. Crotts, G.; Park, T. G. Protein delivery from poly(lactic-co-glycolic acid) biodegradable microspheres: Release kinetics and stability issues J. Microencapsulation 1998, 15 (6) 699-713